Modulation of AMPA/kainate receptors by analogues of diazoxide and cyclothiazide in thin slices of rat hippocampus: M. Bertolino, et al.; Receptors Channels 1, 267 (1993) Abstract 7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide (IDRA 21), a congener of aniracetam, potently abates pharmacologically induced cognitive impairments in patas monkeys: D.M. Thompson, et al.; PNAS 92, 7667 (1995) Abstract 7-Chloro-3-methyl-3-4-dihydro-2H-1,2,4 benzothiadiazine S,S-dioxide (IDRA 21): a benzothiadiazine derivative that enhances cognition by attenuating DL-alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazol: I. Zivkovic, et al.; J. Pharmacol. Exp. Ther. 272, 300 (1995) Abstract Effect of the AMPA receptor modulator IDRA 21 on LTP in hippocampal slices: A. Arai, et al.; Neuroreport 7, 2211 (1996) Abstract 7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide: a partial modulator of AMPA receptor desensitization devoid of neurotoxicity: F. Impagnatiello, et al.; PNAS 94, 7053 (1997) Abstract The diazoxide derivative 7-chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine-S,S-dioxide augments AMPA- and GABA-mediated synaptic responses in cultured hippocampal neurons: K.A. Yamada, et al.; Neurobiol. Dis. 5, 196 (1998) Abstract The diazoxide derivative IDRA 21 enhances ischemic hippocampal neuron injury: K.A. Yamada, et al.; Ann. Neurol. 43, 664 (1998) Abstract
|